Ideal research tool for assay developers creating novel saliva-based SARS-CoV-2 assays, as well as a complete quality solution for clinical laboratories employing such tests. 
 

The product includes positive vials containing the full SARS-CoV-2 viral genome, and human RNase P sequences to monitor sample collection. 
The positive material is configured at 3 different concentrations to enable performance evaluation across the assay range and limit of detection studies. 
 

Negative material containing only RNase P sequences is also included.

​

Features:

• Non-infectious and replication-deficient, enables safe handling in contrast to viral samples

• Fully extractable with a real viral protein coat; superior to “naked” transcribed RNA

• Concentrations of SARS-CoV-2 positive controls: 24,000, 12,000, 6,000 copies/ml and

• one negative control with 0 copy/ml

• Includes negative reference material for targeting sequences for the human RNase P

• gene (24,000 copies/ml)

• 2-year stability at 2 – 8°C

• RUO

​

Click Here for more product information on our partner site